西米替丁佐治肺炎支原体感染的效果评价

刘秀芳; 刘少明; 吴天天

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

x 关闭永久关闭

重要提示

《药学实践与服务》杂志不接收生物战剂、毒剂相关内容的稿件。对于涉军信息类论文如需投稿，请务必投稿前电话或邮箱咨询。联系电话：021-81871323，邮箱：yxsjzzs@163.com。敬请谅解，谢谢配合！

《药学实践与服务》编辑部

重要通知

《药学实践与服务》杂志目前不收取审稿费、版面费、加急费等费用，如收到邮件声称是编辑部X编辑，要求加作者微信的，或填写编委登记申请表的，请谨防诈骗！

编辑部用于作者校稿时微信绑定的邮件是通过官方邮箱：yxsjzzs@163.com发送的，标题是《药学实践与服务》XML数字出版服务微信绑定，请区分开！如有疑虑，请联系编辑部，电话：021-81871323。

《药学实践与服务》编辑部

西米替丁佐治肺炎支原体感染的效果评价

刘秀芳, 刘少明, 吴天天

文章导航 > 药学实践与服务 > 2011 > 29(2): 117-119

刘秀芳, 刘少明, 吴天天. 西米替丁佐治肺炎支原体感染的效果评价[J]. 药学实践与服务, 2011, 29(2): 117-119.

引用本文:

刘秀芳, 刘少明, 吴天天. 西米替丁佐治肺炎支原体感染的效果评价[J]. 药学实践与服务, 2011, 29(2): 117-119.

LIU Xiu-fang, LIU Shao-ming, WU Tian-tian. Evaluation of the therapeutic effect of cimetidine on Mycoplasma pneumoniae infection[J]. Journal of Pharmaceutical Practice and Service, 2011, 29(2): 117-119.

Citation:

LIU Xiu-fang, LIU Shao-ming, WU Tian-tian. Evaluation of the therapeutic effect of cimetidine on Mycoplasma pneumoniae infection[J]. Journal of Pharmaceutical Practice and Service, 2011, 29(2): 117-119.

西米替丁佐治肺炎支原体感染的效果评价

1.
解放军海军总医院,北京 100048
2.
第二军医大学附属长海医院,上海 200433

Evaluation of the therapeutic effect of cimetidine on Mycoplasma pneumoniae infection

1.
General hospital of navy,Beijing 100048, China
2.
Changhai hospital,Shanghai 200433,China

摘要: 目的评价西米替丁佐助阿奇霉素治疗肺炎支原体感染(Mycoplasma pneumoniae infection,MPI)患儿的疗效。方法选择2006年10月~2009年10月在本院就诊的MPI患者80例,随机分组:40例为观察组,40例为对照组,对照组采用阿奇霉素治疗,观察组在予以对照组相同治疗方案的同时,给予西米替丁治疗。用药前和1个疗程后分别检测外周血嗜酸性粒细胞(EOS)和总IgE(T-IgE)并,治疗后评定疗效。结果观察组治愈率为60.00%明显高于对照组的治愈率37.50%,具有统计学意义(P<0.05);观察组在用药前和1个疗程后EOS水平显著下降(P＜0.001),对照组EOS水平也下降,但与治疗前比较差异不显著(P>0.05),两组T-IgE水平基本无变化。不良反应:观察组发生胃肠道反应和皮疹各1例;对照组发生胃肠道反应3例、皮疹2例,两组不良反应率差异不显著(P>0.05)。结论西米替丁佐助阿奇霉素治疗MPI患儿不但疗效佳,而且也相对安全,建议临床进一步推广。
- 西米替丁 /
- 肺炎支原体感染 /
- 阿奇霉素
Abstract: Objective To evaluate the efficacy and safety of cimetidine on Mycoplasma pneumoniae infection. Methonds 80 MPI patients were selected and randomized into the observation group and the control group averagely. The two groups were treated with azithromycin, while the observation group was given cimetidine additionally. Peripheral blood eosinophils (EOS) and total IgE (T-IgE) were detected before and after the treatment which were used to evaluated the effects of cimetidine. Results The cure rate of observation group was 60.00%s and significantly higher than that of the control group which was 37.50% There was statistically significant of the cure rate (P<0.05, see Table 1) between two groups. The EOS level of the observation group decreased significantly after a course of treatment (P<0.001, see Table 2), the EOS level of the control group also decreased but had no significant difference (P>0.05) with the level before treatment. T-IgE level of two groups nearly had no change. The observation group occurred 1case of rash and 1 case of gastrointestinal reaction. The control group occurred 3 cases of gastrointestinal reactions and 2 cases of rash. The adverse reaction rate of two groups had no significant difference (P>0.05). Conclusion Cimetidine for adjuvant treatment of MPI with azithromycin is efficiency and safety which should be recommended in clinic.
- cimetidine /
- Mycoplasma pneumoniae infection /
- azithromycin

[1]	李军,崔其亮,张费通. 布地奈德悬液辅助治疗儿童肺炎支原体感染的疗效[J]. 实用医学杂志,2009,25(15):2550.
[2]	王立凤.小儿支原体肺炎314例临床分析[J].中国临床医生杂志,2008,36(3):43.
[3]	胡亚美,江载芳.诸福棠实用儿科学[M].7版.北京:人民卫生出版社,2002.
[4]	何宗明. 西米替丁佐治小儿肺炎支原体感染72例临床分析[J]. 国际医药卫生导报,2010,16(02):208.
[5]	Yanagihara K, Izumikawa K, Higa F,et al. Efficacy of azithromycin in the treatment of community-acquired pneumonia, including patients with macrolide-resistant Streptococcus pneumoniae infection[J]. Intern Med,2009,48(7):527.
[6]	Morozum IM,Hasegawa K,Chiba N,et al.Application of PCR for Mycoplasm a pneumoniae detection in children with communitvacquired pneumonia[J].Infect Chem other,2004,10(5):274.
[7]	肖选华.西米替丁在儿科临床的新用途[J].医学理论与实践,2004,17(3):281.
[8]	张可林.西米替丁治疗FAPA综合症(周期性发热伴口、咽、颈淋巴结炎综合症)[J].国外医学儿科分册,1992,19(5):279.
[9]	汤光.现代药物学[M].北京:中国科技医药出版社,1996:508.

[1]	葛鹏程, 苏日古嘎, 任天舒, 党大胜. 硫酸黏菌素联合头孢哌酮舒巴坦治疗泛耐药鲍曼不动杆菌肺内感染的疗效分析 . 药学实践与服务, 2026, 44(5): 264-267. doi: 10.12206/j.issn.2097-2024.202404093
[2]	刘志丽, 吴相雷, 胡云英, 王慧, 鲍蕾蕾. 22例免疫检查点抑制剂致免疫相关性肺炎病例分析 . 药学实践与服务, 2026, 44(): 1-4. doi: 10.12206/j.issn.2097-2024.202512023
[3]	邵尉, 于飞, 柳莹, 舒丽芯, 韩丹. 仑卡奈单抗与多奈单抗治疗早期阿尔茨海默病的成本-效用分析 . 药学实践与服务, 2026, 44(): 1-7. doi: 10.12206/j.issn.2097-2024.202601011
[4]	万立志, 王境焓, 吴春蓉, 李玲. 基于代谢组学技术的烟酰胺协同两性霉素B抑制白念珠菌的作用机制研究 . 药学实践与服务, 2026, 44(1): 20-25. doi: 10.12206/j.issn.2097-2024.202307034
[5]	曹秀瑜, 金梦颍, 沈淑琦, 王辉, 洪战英. 细胞代谢组学在阿尔茨海默病药物研究中的应用 . 药学实践与服务, 2026, 44(): 1-8. doi: 10.12206/j.issn.2097-2024.202509026
[6]	张震坡, 何佳欣, 郑靖萍, 王宇婷, 马麟, 宿凌. 基于FAERS数据库对儿童应用大环内酯类抗菌药物的不良事件分析 . 药学实践与服务, 2026, 44(3): 160-166. doi: 10.12206/j.issn.2097-2024.202404031
[7]	郭灵怡, 刘艳超, 高路, 刘瑞瑶, 吕权真, 俞媛. 醋酸卡泊芬净单硬脂酸甘油酯纳米粒抗白色念珠菌感染的增效作用研究 . 药学实践与服务, 2025, 43(3): 136-142, 150. doi: 10.12206/j.issn.2097-2024.202310043
[8]	冯广伟, 张静, 刘阳熙, 崔敏. 消化道穿孔患者术后继发念珠菌血流感染的病例分析 . 药学实践与服务, 2025, 43(9): 463-465. doi: 10.12206/j.issn.2097-2024.202312012
[9]	贾婷婷, 张立超. 纳米技术在烧伤局部抗感染中的应用 . 药学实践与服务, 2025, 43(11): 529-532, 539. doi: 10.12206/j.issn.2097-2024.202305055
[10]	刘彬果, 吴葆婷, 王剑丽, 陈竹卿. 中药防治流感病毒性肺炎的作用及机制研究进展 . 药学实践与服务, 2025, 43(11): 540-547. doi: 10.12206/j.issn.2097-2024.202402033
[11]	晁亮, 王辉, 沈淑琦, 游飘雪, 冀凯宏, 洪战英. 基于UHPLC-Q/TOF-MS代谢组学策略的葛根-知母药对防治阿尔茨海默病的药效与作用机制研究 . 药学实践与服务, 2025, 43(1): 30-40. doi: 10.12206/j.issn.2097-2024.202409035
[12]	史生辉, 石飞, 雷琼, 王亚峰, 吴雪花. 青藏高原肺结核合并念珠菌感染患者的病原菌分布特点及耐药率分析 . 药学实践与服务, 2024, 42(6): 260-262, 272. doi: 10.12206/j.issn.2097-2024.202304014
[13]	陈金涛, 乔子婴, 马明华, 张若曦, 王振伟, 年华. 基于网络药理学和分子对接技术研究金芪清疏颗粒治疗社区获得性肺炎的潜在机制 . 药学实践与服务, 2024, 42(11): 471-478. doi: 10.12206/j.issn.2097-2024.202312014
[14]	黄韵, 张正银, 金英, 郑怡菁, 李铁军, 孙莉莉. 耐碳青霉烯类肺炎克雷伯菌及大肠埃希菌临床分离株耐药性及耐药基因分析 . 药学实践与服务, 2024, 42(10): 439-444. doi: 10.12206/j.issn.2097-2024.202309059
[15]	张晶晶, 索丽娜, 郑兆红. 89例细菌性肝脓肿的临床特征及抗感染治疗分析 . 药学实践与服务, 2024, 42(6): 267-272. doi: 10.12206/j.issn.2097-2024.202302039
[16]	尹小娟, 台力丽, 肖俊峰, 季波. 铜绿假单胞菌合并按蚊伊丽莎白菌肺部感染的病例分析 . 药学实践与服务, 2024, 42(5): 223-226. doi: 10.12206/j.issn.2097-2024.202310042

点击查看大图

计量

文章访问数: 3841
HTML全文浏览量: 455
PDF下载量: 193
被引次数: 0

西米替丁佐治肺炎支原体感染的效果评价

1. 解放军海军总医院,北京 100048

2. 第二军医大学附属长海医院,上海 200433

收稿日期: 2010-04-19
修回日期: 2010-07-07

关键词:

西米替丁 /

肺炎支原体感染 /

阿奇霉素

摘要: 目的评价西米替丁佐助阿奇霉素治疗肺炎支原体感染(Mycoplasma pneumoniae infection,MPI)患儿的疗效。方法选择2006年10月~2009年10月在本院就诊的MPI患者80例,随机分组:40例为观察组,40例为对照组,对照组采用阿奇霉素治疗,观察组在予以对照组相同治疗方案的同时,给予西米替丁治疗。用药前和1个疗程后分别检测外周血嗜酸性粒细胞(EOS)和总IgE(T-IgE)并,治疗后评定疗效。结果观察组治愈率为60.00%明显高于对照组的治愈率37.50%,具有统计学意义(P<0.05);观察组在用药前和1个疗程后EOS水平显著下降(P＜0.001),对照组EOS水平也下降,但与治疗前比较差异不显著(P>0.05),两组T-IgE水平基本无变化。不良反应:观察组发生胃肠道反应和皮疹各1例;对照组发生胃肠道反应3例、皮疹2例,两组不良反应率差异不显著(P>0.05)。结论西米替丁佐助阿奇霉素治疗MPI患儿不但疗效佳,而且也相对安全,建议临床进一步推广。

English Abstract

Evaluation of the therapeutic effect of cimetidine on Mycoplasma pneumoniae infection

1. General hospital of navy,Beijing 100048, China

2. Changhai hospital,Shanghai 200433,China

Received Date: 2010-04-19
Rev Recd Date: 2010-07-07

Keywords:

Abstract: Objective To evaluate the efficacy and safety of cimetidine on Mycoplasma pneumoniae infection. Methonds 80 MPI patients were selected and randomized into the observation group and the control group averagely. The two groups were treated with azithromycin, while the observation group was given cimetidine additionally. Peripheral blood eosinophils (EOS) and total IgE (T-IgE) were detected before and after the treatment which were used to evaluated the effects of cimetidine. Results The cure rate of observation group was 60.00%s and significantly higher than that of the control group which was 37.50% There was statistically significant of the cure rate (P<0.05, see Table 1) between two groups. The EOS level of the observation group decreased significantly after a course of treatment (P<0.001, see Table 2), the EOS level of the control group also decreased but had no significant difference (P>0.05) with the level before treatment. T-IgE level of two groups nearly had no change. The observation group occurred 1case of rash and 1 case of gastrointestinal reaction. The control group occurred 3 cases of gastrointestinal reactions and 2 cases of rash. The adverse reaction rate of two groups had no significant difference (P>0.05). Conclusion Cimetidine for adjuvant treatment of MPI with azithromycin is efficiency and safety which should be recommended in clinic.

刘秀芳, 刘少明, 吴天天. 西米替丁佐治肺炎支原体感染的效果评价[J]. 药学实践与服务, 2011, 29(2): 117-119.

引用本文:

刘秀芳, 刘少明, 吴天天. 西米替丁佐治肺炎支原体感染的效果评价[J]. 药学实践与服务, 2011, 29(2): 117-119.

Citation: